Antimicrobial Peptide Discovery on AMP Discovery epsilon=0.1
113,658.2Unique Predicted-Resistant PeptidesB2-TR
Evaluation results
| Method | Links | |
|---|---|---|
| B2-TRModel=Boosted GFlowNet, Number of models=2, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 113,658.2 | |
| B3-TRModel=Boosted GFlowNet, Number of models=3, Objective variant=Target-Residual (TR), Alpha=0.02025.11 | 108,205.8 | |
| B2-FAModel=Boosted GFlowNet, Number of models=2, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 72,602.4 | |
| B3-FAModel=Boosted GFlowNet, Number of models=3, Objective variant=Flow-Additive (FA), Alpha=1.02025.11 | 71,714 | |
| SGModel=Single GFlowNet, Number of models=12025.11 | 70,362.8 |